Gocovri vs. Rytary

Are Gocovri and Rytary the Same Thing?

Gocovri (amantadine extended release capsules) and Rytary (carbidopa and levodopa) are used to treat abnormal/involuntary muscle movement (dyskinesia) in patients with Parkinson's disease.

Rytary is also used to treat post-encephalitic Parkinsonism and Parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Gocovri is an antivirial and anti-Parkinson drug and Rytary is a combination an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid.

Side effects of Gocovri and Rytary that are similar include dizziness, dry mouth, constipation, and dizziness on standing (orthostatic hypotension).

Side effects of Gocovri that are different from Rytary include hallucinations, swelling of extremities, and falls.

Side effects of Rytary that are different from Gocovri include nausea, headache, insomnia, abnormal dreams, involuntary movements, anxiety, vomiting, and low blood pressure.

Gocovri may interact with other anticholinergic drugs, carbonic anhydrase inhibitors, sodium bicarbonate, alcohol, and "live" vaccines.

Rytary may interact with MAO inhibitors, phenothiazines, butyrophenones, risperidone, metoclopramide, isoniazid, iron salts, and multi-vitamins containing iron salts.

What Are Possible Side Effects of Gocovri?

Common side effects of Gocovri include:

  • hallucinations,
  • dizziness,
  • dry mouth,
  • swelling of extremities,
  • constipation,
  • falls,
  • and dizziness on standing (orthostatic hypotension).

Other side effects of Gocovri include:

What Are Possible Side Effects of Rytary?

Common side effects of Rytary include:

  • nausea,
  • dizziness,
  • headache,
  • insomnia,
  • abnormal dreams,
  • dry mouth,
  • involuntary movements,
  • anxiety,
  • constipation,
  • vomiting, and
  • low blood pressure and dizziness upon standing (orthostatic hypotension)

What Is Gocovri?

Gocovri (amantadine extended release capsules) is an antivirial and anti-Parkinson drug indicated for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.

What Is Rytary?

Rytary (carbidopa and levodopa) is a combination an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid, used for the treatment of Parkinson's disease, post-encephalitic Parkinsonism, and Parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

SLIDESHOW

Dementia, Alzheimer's Disease, and Aging Brains See Slideshow

What Drugs Interact With Gocovri?

Gocovri may interact with other anticholinergic drugs, carbonic anhydrase inhibitors, sodium bicarbonate, alcohol, and “live” vaccines. Tell your doctor all medications and supplements you use and all vaccines you recently received. Gocovri is not recommended for use during pregnancy; it may harm a fetus. Gocovri passes into breast milk but its effect on nursing infants is unknown. Gocovri may alter breast milk production or excretion. Consult your doctor before breastfeeding.

What Drugs Interact With Rytary?

Rytary may interact with MAO inhibitors, phenothiazines, butyrophenones, risperidone, metoclopramide, isoniazid, iron salts, or multi-vitamins containing iron salts. Tell your doctor all medications and supplements you use. During pregnancy, Rytary should be used only if prescribed. These drugs may pass into breast milk. Consult your doctor before breastfeeding.

How Should Gocovri Be Taken?

The initial daily dosage of Gocovri is 137 mg, administered orally once daily at bedtime. After one week, increase to the recommended dosage of 274 mg (two 137 mg capsules) once daily at bedtime.

How Should Rytary Be Taken?

The recommended starting dosage of Rytary is 23.75 mg/95 mg taken orally three times a day for the first 3 days. On the fourth day of treatment, the dosage of Rytary may be increased to 36.25 mg/145 mg taken three times a day.

QUESTION

Parkinson's disease is only seen in people of advanced age. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Adamas Pharmaceuticals, Inc. Gocovri Product Information.

https://www.gocovri.com

Amneal Pharmaceuticals LLC. Osmolex ER Prescribing Information.

www.rytary.com/?

Health Solutions From Our Sponsors